Kymera Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
Globe Newswire•22/10/2026•16:01 ET
0
Key Highlights
- ➤Kymera (KYMR) will report third quarter 2026 financial results October 29, 2026
- ➤Video conference call and webcast scheduled for 8:30 a.m. ET October 29
WATERTOWN, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will report third quarter 2026 financial results on October 29, 2026. The Company will host a video conference call and webcast at 8:30 a.m. ET that day.
To join the video call or view the livestreamed webcast, please register via this link, or visit “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. A replay of the webcast will be archived and available following the event.
Get started
Create a free account to read the full story.